I can understand the wooden chair and all want to keep their comfy cushion chairs till the time is right for Peregrine.... but I wonder what type of chair Rahul ex-Peregrine analyst sits on these days? : ) I was hoping some others would start speaking out and aim for a BOD position somewhere...
That entire thing still has me thinking and wondering that if Rahul knew so much there still must be some more trying to position themselves but I hope Peregrine wants to surprise us a bit sooner than later
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!